Supplementary Table 2.
Variables | Alcoholic hepatitis |
||
---|---|---|---|
Before COVID (n = 539) | COVID (n = 231) | P value | |
Male sex, n (%) | 312 (57.9) | 143 (61.9) | .30 |
Age at admission, y, median (IQR) | 47 (39–55) | 43 (36–53) | .04 |
Rural residence, n (%) | 110 (20.4) | 77 (33.3) | <.01 |
Hepatitis B infection | 15 (2.8) | 5 (12.2) | .62 |
Hepatitis C infection | 81 (15.0) | 24 (10.4) | .09 |
Having decompensated cirrhosis | 207 (38.4) | 85 (36.8) | .67 |
Ascites | 142 (26.4) | 60 (26.0) | .92 |
Hepatic decompensation | 32 (5.9) | 15 (6.5) | .77 |
Esophageal/gastric varices | 53 (9.8) | 20 (8.7) | .61 |
Hepatocellular carcinoma | 5 (0.9) | 1 (0.4) | .47 |
Maddrey DF score, median (IQR) | 44.2 (25.4–64.8) | 47.5 (25.4–70.9) | .50 |
Charlson comorbidity score | |||
0 | 272 (50.5) | 123 (53.3) | .42 |
1 | 179 (33.2) | 74 (32.0) | |
2 | 17 (3.2) | 11 (4.8) | |
≥3 | 71 (13.2) | 23 (10.0) | |
Intensive care unit admission | 71 (13.2) | 29 (12.6) | .82 |
Inpatient mortality | 63 (11.7) | 26 (11.3) | .86 |
COVID-19, coronavirus disease 2019; IQR, interquartile range; Maddery DF, Maddery discriminant function.